trial

Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

NCTId NCT01181960

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

Phase — · Completed

Enrollment 1,066 (actual)

Sponsored by Janssen, L.P. - Investigator Initiated Studies Program

Primary completion 2013-11

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Completed

Enrollment

1,066 (actual)

Study type

Observational

Allocation

—

Model

—

Masking

—

Start

2010-08

Primary completion

2013-11

Eligibility

ALL · 18 Years · 64 Years

Interventions & indications

Drugs

Risperidone Paliperidone Other Antipsychotics - New Starts

Indications

Schizophrenia Bipolar Disorder Bipolar Disorder Schizophrenia

Sites

34 total

Bullhead City, United StatesColton, United StatesImperial, United StatesNorwalk, United StatesAurora, United StatesLeesburg, United StatesMiami, United StatesMacon, United StatesPeoria, United StatesSpringfield, United StatesBloomington, United StatesBaton Rouge, United States